Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Microbianos Market by Type (Bacteria, Fungi, Algae, Protozoa, Others), By Application (Pharmaceutical, Food Process, Agriculture, Chemical Industry, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Microbianos Market by Type (Bacteria, Fungi, Algae, Protozoa, Others), By Application (Pharmaceutical, Food Process, Agriculture, Chemical Industry, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 260052 4200 Chemical & Material 377 197 Pages 4.6 (40)
                                          

Market Overview:


The global microbianos market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for microbial products in pharmaceutical, food processing, agriculture, and chemical industries. North America is expected to dominate the global microbianos market during the forecast period owing to the presence of key players and technological advancements in this region.


Global Microbianos Industry Outlook


Product Definition:


Microbianos are a type of bacteria that is beneficial to the body. They play an important role in digestion and help keep the gut healthy.


Bacteria:


Bacteria is a vital component of the microbiology industry. It is used in various applications such as food and beverage processing, pharmaceuticals, biotechnology, water treatment and biofuel production. Bacteria are also used for research purposes in order to study microorganisms or microbes more accurately.


Fungi:


Fungi is a eukaryotic organisms that includes molds and mildews as well as mushrooms. Fungi can be classified on the basis of their size, shape, nutritional requirements, and reproductive methods.


Application Insights:


The global market is segmented by application into pharmaceutical, food process, agriculture and chemical industry. The pharmaceutical segment dominated the overall market in terms of revenue in 2017. This can be attributed to the high usage of microorganisms for producing drugs such as antibiotics and antimalarials. Microbial fermentation is one of the most effective ways to produce pharma-grade medicines with higher purity levels than those produced by conventional methods.


Microbial enzymes play a significant role in several industrial processes including alcohols & acidsogenesis (the production of acetic acid), lactic acid manufacture (from lactose), cellulosic conversion (to cellobiose and then to glucose)and fatty acid synthesis from oleic acid or linoleic acid (for use as an energy source).


Regional Analysis:


Europe dominated the global market in terms of revenue share in 2017. The growth is attributed to the presence of a large number of microbiano manufacturers and suppliers coupled with high demand for medicines, chemicals, and food products. Asia Pacific is expected to witness significant growth over the forecast period owing to increasing awareness regarding benefits offered by these organisms as compared to synthetic counterparts. This region has several potential players who are focusing on entering into new markets so as to expand their business operations globally. For instance, Novotech Ltd., UPM Biomedicals Inc., FUJIFILM Diosynth Biotechnologies UG (Germany), Avantor Performance Materials Inc (U.S.


The global market has been segmented into North America; Europe; Asia Pacific; Latin America;.


Growth Factors:


  • Increasing awareness about the benefits of probiotics: There is a growing awareness among people about the benefits of probiotics, which is driving demand for microbianos products.
  • Rising incidence of lifestyle diseases: The incidence of lifestyle diseases such as obesity, diabetes, and heart disease is rising globally, which is leading to an increase in demand for probiotic supplements.
  • Growing popularity of fermented foods: Fermented foods are becoming increasingly popular due to their health benefits, and this is boosting demand for microbianos products.
  • increasing research on the health benefits of probiotics: There has been a surge in research on the health benefits of probiotics in recent years, which is fueling growth in the microbianos market.

Scope Of The Report

Report Attributes

Report Details

Report Title

Microbianos Market Research Report

By Type

Bacteria, Fungi, Algae, Protozoa, Others

By Application

Pharmaceutical, Food Process, Agriculture, Chemical Industry, Others

By Companies

Johnson&Johnson, Roche, Pfizer, Novartis, Merck, Amgen, Sanofi, Abbvie, Celgene, Bayer, Johnson&Johnson

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

197

Number of Tables & Figures

138

Customization Available

Yes, the report can be customized as per your need.


Global Microbianos Market Report Segments:

The global Microbianos market is segmented on the basis of:

Types

Bacteria, Fungi, Algae, Protozoa, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical, Food Process, Agriculture, Chemical Industry, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Johnson&Johnson
  2. Roche
  3. Pfizer
  4. Novartis
  5. Merck
  6. Amgen
  7. Sanofi
  8. Abbvie
  9. Celgene
  10. Bayer
  11. Johnson&Johnson

Global Microbianos Market Overview


Highlights of The Microbianos Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Bacteria
    2. Fungi
    3. Algae
    4. Protozoa
    5. Others
  1. By Application:

    1. Pharmaceutical
    2. Food Process
    3. Agriculture
    4. Chemical Industry
    5. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Microbianos Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Microbianos Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Some of the major companies in the microbianos market are Johnson&Johnson, Roche, Pfizer, Novartis, Merck, Amgen, Sanofi, Abbvie, Celgene, Bayer, Johnson&Johnson.

The microbianos market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Microbianos Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Microbianos Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Microbianos Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Microbianos Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Microbianos Market Size & Forecast, 2018-2028       4.5.1 Microbianos Market Size and Y-o-Y Growth       4.5.2 Microbianos Market Absolute $ Opportunity

Chapter 5 Global Microbianos Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Microbianos Market Size Forecast by Type
      5.2.1 Bacteria
      5.2.2 Fungi
      5.2.3 Algae
      5.2.4 Protozoa
      5.2.5 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Microbianos Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Microbianos Market Size Forecast by Applications
      6.2.1 Pharmaceutical
      6.2.2 Food Process
      6.2.3 Agriculture
      6.2.4 Chemical Industry
      6.2.5 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Microbianos Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Microbianos Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Microbianos Analysis and Forecast
   9.1 Introduction
   9.2 North America Microbianos Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Microbianos Market Size Forecast by Type
      9.6.1 Bacteria
      9.6.2 Fungi
      9.6.3 Algae
      9.6.4 Protozoa
      9.6.5 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Microbianos Market Size Forecast by Applications
      9.10.1 Pharmaceutical
      9.10.2 Food Process
      9.10.3 Agriculture
      9.10.4 Chemical Industry
      9.10.5 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Microbianos Analysis and Forecast
   10.1 Introduction
   10.2 Europe Microbianos Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Microbianos Market Size Forecast by Type
      10.6.1 Bacteria
      10.6.2 Fungi
      10.6.3 Algae
      10.6.4 Protozoa
      10.6.5 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Microbianos Market Size Forecast by Applications
      10.10.1 Pharmaceutical
      10.10.2 Food Process
      10.10.3 Agriculture
      10.10.4 Chemical Industry
      10.10.5 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Microbianos Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Microbianos Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Microbianos Market Size Forecast by Type
      11.6.1 Bacteria
      11.6.2 Fungi
      11.6.3 Algae
      11.6.4 Protozoa
      11.6.5 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Microbianos Market Size Forecast by Applications
      11.10.1 Pharmaceutical
      11.10.2 Food Process
      11.10.3 Agriculture
      11.10.4 Chemical Industry
      11.10.5 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Microbianos Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Microbianos Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Microbianos Market Size Forecast by Type
      12.6.1 Bacteria
      12.6.2 Fungi
      12.6.3 Algae
      12.6.4 Protozoa
      12.6.5 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Microbianos Market Size Forecast by Applications
      12.10.1 Pharmaceutical
      12.10.2 Food Process
      12.10.3 Agriculture
      12.10.4 Chemical Industry
      12.10.5 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Microbianos Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Microbianos Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Microbianos Market Size Forecast by Type
      13.6.1 Bacteria
      13.6.2 Fungi
      13.6.3 Algae
      13.6.4 Protozoa
      13.6.5 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Microbianos Market Size Forecast by Applications
      13.10.1 Pharmaceutical
      13.10.2 Food Process
      13.10.3 Agriculture
      13.10.4 Chemical Industry
      13.10.5 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Microbianos Market: Competitive Dashboard
   14.2 Global Microbianos Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Johnson&Johnson
      14.3.2 Roche
      14.3.3 Pfizer
      14.3.4 Novartis
      14.3.5 Merck
      14.3.6 Amgen
      14.3.7 Sanofi
      14.3.8 Abbvie
      14.3.9 Celgene
      14.3.10 Bayer
      14.3.11 Johnson&Johnson

Our Trusted Clients

Contact Us